Vanguard Total Stock Market ETF (VTI)

Multiple brokerages cut their price target on the stock after Doximity reported a fall in third-quarter earnings and a soft fourth-quarter revenue outlook.

Cantor Fitzgerald noted that Amazon’s $200 billion capital expenditure plans could reignite concerns around long-term return on invested capital.

Supporters of the bullish case point to aggressive capital expenditure plans by major technology companies, which they believe will eventually benefit Nvidia.

The data center developer company on Thursday reported an adjusted core loss of $295.4 million, compared to the profit of $321.6 million recorded in the corresponding period a year ago.

Affirm Holdings saw its provision for credit losses jump to $214.2 million in the second quarter compared to nearly $153 million from the same quarter a year ago.

Revenue for the quarter, meanwhile, came in at $11.38 billion, exceeding a Wall Street estimate of $10.9 billion.

The Future Fund Managing Partner Gary Black said in a post on X on Thursday that nothing indicates more confidence in a company than its CEO buying shares.

Meta is positioning artificial intelligence at the core of its business strategy following stronger-than-expected fourth-quarter results and outlining ambitious plans for 2026.

B. Riley upgraded Snap to ‘Buy’ from ‘Neutral’ and kept its price target unchanged at $10, implying a 70% upside from Wednesday’s close.

Warren Buffett rarely makes market predictions, but he stood firm on this one.

The European Commission on Thursday stated that Apple Maps and Ads do not constitute an important gateway for business users to reach end users.

Shares of both companies tumbled about 15% on Wednesday at the time of writing.

Tesla recorded a 9.3% increase in wholesale sales in January, according to a report by CNEVPost.

Texas Instruments said that it will acquire Silicon Labs for $231.00 per share in an all-cash transaction, representing a total enterprise value of approximately $7.5 billion.

In a chat with Reliance Industries CEO Mukesh Ambani, organized by Moneycontrol, Fink stated that it is necessary to rapidly expand AI opportunities.

Prelude Therapeutics said on Tuesday that the FDA gave clearances to proceed with early-stage trials for its experimental drug PRT12396.

Intel CEO Lip-Bu Tan said at the Cisco AI Summit on Tuesday that the company has appointed a new chief architect for the graphics processing units.